[123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor vs. akinetic-rigid onset

NeuroReport

Volumn 18, Issue 14, 2007, Pages 1499-1502

  Isaias, Ioannis U ^a,b   Benti, Riccardo ^c   Cilia, Roberto ^a,b   Canesi, Margherita ^a   Marotta, Giorgio ^c   Gerundini, Paolo ^c   Pezzoli, Gianni ^a   Antonini, Angelo ^a  

^a PARKINSON INSTITUTE   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

123I FP CIT; Dopamine transporter; Parkinsons disease; SPECT; Tremor at rest

Indexed keywords

N (3 FLUOROPROPYL) 2 BETA CARBOMETHOXY 3 BETA (4 IODOPHENYL)NORTROPANE I 123; RADIOLIGAND; UNCLASSIFIED DRUG; 2 CARBOMETHOXY 8 (3 FLUOROPROPYL) 3 (4 IODOPHENYL)TROPANE; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; RADIOACTIVE IODINE; TROPANE DERIVATIVE;

ADULT; AKINESIA; ARTICLE; BRAIN DEGENERATION; CAUDATE NUCLEUS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE DURATION; DISEASE SEVERITY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; MUSCLE RIGIDITY; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRIATONIGRAL DEGENERATION; TREMOR; AGED; IMAGE PROCESSING; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

AGED; CORPUS STRIATUM; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MUSCLE RIGIDITY; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREMOR; TROPANES;

EID: 34548073310     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3282ef69f9     Document Type: Article

References (25)

1. Hughes A, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55:181-184.
2. Louis ED, Tang MX, Cote L, Alfaro B, Mejia H, Marder K. Progression of parkinsonian signs in Parkinson disease. Arch Neurol 1999; 56:334-337.
3. Antonini A, Moeller JR, Nakamura T, Spetsieris P, Dhawan V, Eidelberg D. The metabolic anatomy of tremor in Parkinson's disease. Neurology 1998; 51:803-810.
4. 123I]-β-CIT SPECT. J Neurol 1998; 245:14-20.
5. Rajput AH, Rozdilsky B, Ang L. Occurrence of resting tremor in Parkinson's disease. Neurology 1991; 41:1298-1299.
6. Paulus W, Jellinger K. The neuropathologic basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 1991; 50:743-755.
7. Hughes A, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50:140-148.
8. Deuschl G, Raethjen J, Baron R, Lindemann M, Wilms H, Krack P. The pathophysiology of parkinsonian tremor: a review. J Neurol 2000; 247(Suppl 5):S33-S48.
9. 123I]-FP-CIT SPECT striatal uptake. Mov Disord 2000; 15:692-698.
10. Isaias IU, Benti R, Goldwurm S, Zini M, Cilia R, Gerundini P, et al. Striatal dopamine transporter binding in Parkinson's disease associated with the LRKK2 Gly2019Ser mutation. Mov Disord 2006; 21:1144-1147.
11. Collins DL, Zijdenbos AP, Kollokian V, Sled JG, Kabani NJ, Holmes CJ, et al. Design and construction of a realistic digital brain phantom. IEEE Trans Med Imaging 1998; 17:463-468.
12. Tzourio-Mazoyer N, De Schonen S, Crivello F, Reutter B, Aujard Y, Mazoyer B. Automated anatomical labelling of activations in spm using a macroscopic anatomical parcellation of the MNI MRI single subject brain. NeuroImage 2002; 15:273-289.
13. 123I]-β-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. J Neurol Transm 1997; 50:9-24.
14. Spiegel J, Hellwig D, Samnick S, Jost W, Mollers MO, Fassbender K, et al. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease. J Neural Transm 2007; 114:331-335.
15. 11C]d-threomethylphenidate PET in patients with Parkinson's disease and essential tremor. J Neural Transm 2006; 113:187-193.
16. 18F-dopa study. Neurology 1992; 42:1554-1560.
17. Bergman H, Raz A, Feingold A, Nini A, Nelken I, Hansel D, et al. Physiology of MPTP tremor. Mov Disord 1998; 13:29-34.
18. Sotnikova TD, Caron MG, Gainetdinov RR. DDD mice, a novel acute mouse model of Parkinson's disease. Neurology 2006; 67(Suppl 2):S12-S17.
19. Ghaemi M, Raethjen J, Hilker R, Rudolf J, Sobesky J, Deuschl G, et al. Monosymptomatic resting tremor and Parkinson's disease: multicenter positron emission tomographic study. Mov Disord 2002; 4:782-788.
20. Lenz FA, Jaeger CJ, Seike MS, Lin YC, Reich SG. Single unit analysis of the human ventral thalamic nuclear group. Tremor-related activity in functionally identified cells. Brain 1994; 117:531-543.
21. Rodriguez MC, Guridi OJ, Alvarez L, Mewes K, Macias R, Vitek J, et al. The subthalamic nucleus and tremor in Parkinson's disease. Mov Disord 1998; 13:111-118.
22. Hutchison WD, Lozano AM, Tasker RR, Lang AE, Dostrovsky JO. Identification and characterization of neurons with tremor-frequency activity in human globus pallidus. Exp Brain Res 1997; 113:557-563.
23. Kopell BH, Rezai AR, Chang JW, Vitek JL. Anatomy and physiology of the basal ganglia: implications for deep brain stimulation for Parkinson's disease. Mov Disord 2006; 21:238-246.
24. Brodkey JA, Tasker RR, Hamani C, McAndrews MP, Dostrovsky JO, Lozano AM. Tremor cells in the human thalamus: differences among neurological disorders. J Neurosurg 2004; 101:43-47.
25. Lalley FM, Rossi GV, Baker WW. Tremor induction by intracaudate injections of bretylium, tetrabenazine, or mescaline: functional deficits in the caudate dopamine. J Pharm Sci 1973; 62:1302-1307.